Corbus Pharmaceuticals Holdings (CRBP) Depreciation and Depletion (2014 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Depreciation and Depletion came in at $100000.0 in Q3 2025, down 50.0% year-on-year from $200000.0 in Q3 2024, and little changed quarter-over-quarter from $100000.0 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) Depreciation and Depletion (2014 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Depreciation and Depletion history runs 10 years deep, the most recent figure standing at $100000.0 for Q3 2025.
- On a quarterly basis, Depreciation and Depletion fell 50.0% year-over-year to $100000.0 in Q3 2025; TTM through Sep 2025 was $400000.0, a 42.86% decrease from a year earlier, with the FY2024 full-year figure at $600000.0, changed 0.0% from the prior year.
- Depreciation and Depletion steadied at $100000.0 in Q3 2025 per CRBP's latest filing, from $100000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $272186.0 in Q1 2021 and bottomed at $100000.0 in Q4 2023.
- The 5-year median for Depreciation and Depletion is $195719.0 (2022), against an average of $181308.9.
- Across the five-year window, Depreciation and Depletion gained 26.82% in 2021 and sank 50.0% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $207868.0 in 2021, then declined by 11.29% to $184402.0 in 2022, then sank by 45.77% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Per Business Quant, the three latest CRBP Depreciation and Depletion figures stand at $100000.0 (Q3 2025), $100000.0 (Q2 2025), and $100000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |